Wang, Li
Liu, Xiangyang
Yang, Wenjuan
Lai, Jingbo
Yu, Xinwen
Liu, Jianrong
Gao, Xiling
Ming, Jie
Ma, Kaiyan
Xu, Jing
Tian, Zhufang
He, Qingzhen
Ji, Qiuhe http://orcid.org/0000-0002-3010-5837
Clinical trials referenced in this document:
Documents that mention this clinical trial
Comparison of Blood Glucose Variability Between Exenatide and Biphasic Insulin Aspart 30 in Chinese Participants with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A Multicenter, Open-Label, Randomized Trial
https://doi.org/10.1007/s13300-020-00904-z
Funding for this research was provided by:
AstraZeneca China and 3SBio Inc (ESR-14-10319)
Nation Key Research and Development Program of China (2017YFC1309803)
Key Research and Development Program of Shaanxi Province, China (2017ZDCXLSF0201)
Article History
Received: 2 June 2020
First Online: 27 August 2020